From the floor in Tianjin: 9 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The archive — 2025
Page 37 of 68 of this archive, newest first.
The 27-day notice: how a compounding wind-down works in Brazil
The document is four pages. Three of them are about dates.
What a 32% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
What the trials counted as intolerance
Trial discontinuation figures are a floor, not an estimate: trial populations are supported in ways ordinary patients are not.
What changed at CPC in June, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new Brazil guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Hong Kong: 5 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Japan declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
SURMOUNT-2 was built to answer the stopping question, and it did
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
Bacteriostatic water, sterile water, and the 0.9 per cent that makes the difference
We set out what is known, what is inferred and what is simply assumed about the fortnight after a vial is opened.
Assay against a standard, or area per cent: two different questions
We asked the four independent testing services what standards they run against and what suitability criteria they apply. The answers are printed.
STEP 8 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A supplier suspends shipping to France after 18 consecutive customs detentions
The route did not close because of a rule about peptides.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
PeptideMeter result on a Hong Kong mazdutide lot lands 1.4 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Pancreatitis, obstruction, gallbladder: three things nausea can be
A small number of serious gastrointestinal events occur in people taking these drugs. Distinguishing them from the expected effect profile is the most consequential…
The dose that got you here and the dose that keeps you here
Every withdrawal trial compared full dose against nothing. The clinically interesting comparison — full dose against a reduced one — has not been randomised.
The 11-day notice: how a compounding wind-down works in Italy
The document is four pages. Three of them are about dates.
Nantong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a SGN semaglutide lot at 96.6%, against 94.9% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
Independent analysis puts a JEEP retatrutide lot at 96.6%, against 92.9% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Six words a verification badge would need to mean anything
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
Resolving power and mass accuracy are two different specifications
Parts per million sound impressive until they are converted into daltons at the molecular weight of the thing being measured.
What changed at GL Biochem in June, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Germany caps dulaglutide prescribing to 6 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
From the floor in Shenzhen: 12 posters, one theme
Reported from the sessions, and from the two hours afterwards.
LAL, kinetic chromogenic, recombinant factor C: three ways to the same figure
We submitted vials for endotoxin determination and report the results, the method and the laboratory, because a pyrogen figure without a method is as empty as a purity…
The three-times-upper-limit convention, and where it came from
What the renal and hepatic outcome programmes actually measured, and over what duration.
KP declines, for the 13th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Ireland declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.